1. Home
  2. EE vs ALVO Comparison

EE vs ALVO Comparison

Compare EE & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Excelerate Energy Inc.

EE

Excelerate Energy Inc.

HOLD

Current Price

$35.70

Market Cap

1.1B

Sector

Utilities

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$3.70

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EE
ALVO
Founded
2003
2013
Country
United States
Luxembourg
Employees
N/A
1460
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
EE
ALVO
Price
$35.70
$3.70
Analyst Decision
Buy
Buy
Analyst Count
5
4
Target Price
$39.20
$8.00
AVG Volume (30 Days)
340.3K
1.1M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
0.96%
N/A
EPS Growth
0.79
N/A
EPS
0.37
N/A
Revenue
$1,228,263,000.00
N/A
Revenue This Year
$23.59
$13.28
Revenue Next Year
$24.37
$18.63
P/E Ratio
$97.46
$18.20
Revenue Growth
44.26
N/A
52 Week Low
$21.29
$2.94
52 Week High
$43.18
$9.94

Technical Indicators

Market Signals
Indicator
EE
ALVO
Relative Strength Index (RSI) 58.34 49.75
Support Level $35.10 $3.65
Resistance Level $35.73 $3.83
Average True Range (ATR) 1.13 0.32
MACD 0.35 -0.03
Stochastic Oscillator 80.55 39.24

Price Performance

Historical Comparison
EE
ALVO

About EE Excelerate Energy Inc.

Excelerate Energy Inc. offers comprehensive LNG solutions by providing integrated services throughout the LNG value chain. The company delivers a full range of regasification services, including Floating Storage and Regasification Units (FSRUs), infrastructure development, and the supply of LNG and natural gas. With operational presence in several countries - Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States. The company generates revenue through Terminal Services, as well as from LNG, gas, and power. These revenues are derived from its vertically integrated activities in LNG sourcing, transportation, regasification, and power generation.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: